Characterisation of families with hereditary prostate cancer in the Netherlands;Karakterisering van families met hereditair prostaatcarcinoom in Nederland

Nederlands Tijdschrift voor Geneeskunde

Volumn 146, Issue 41, 2002, Pages 1938-1942

  Meulenbeld, H J ^a   Verhage, B A J ^a   Kil, P J M ^a   Kiemeney, L A L M ^a   Vasen, H F A ^a  

^a Stichting Opsporing Erfelijke Tumoren   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEATH; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; MALE; NETHERLANDS; PROSTATE CARCINOMA; RISK FACTOR;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICIPATION, GENETIC; CARCINOMA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PEDIGREE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGISTRIES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0037069030     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Visser O, Coebergh JWW, Schouten LJ, Dijck JAAM van, editors. Incidence of cancer in the Netherlands 1997. Utrecht: Vereniging van Integrale Kankercentra; 2001.
2. Kiemeney LALM. Hereditair prostaatcarcinoom: de rol van de uroloog. Nederlands Tijdschrift voor Urologie 2001;2:35-41.
3. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992;89:3367-71.
4. Grönberg H, Damber L, Damber JE, Iselius L. Segregation analysis of prostate cancer in Sweden: support for dominant inheritance. Am J Epidemiol 1997;146:552-7.
5. Schaid DJ, McDonnell SK, Blute ML, Thibodeau SN. Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet 1998;62:1425-38.
6. Verhage BAJ, Baffoe-Bonnie AB, Baglietto L, Smith DS, Bailey-Wilson JE, Beaty TH, et al. Autosomal dominant inheritance of prostate cancer: a confirmatory study. Urology 2001;57:97-101.
7. Grönberg H, Bergh A, Damber JE, Emanuelsson M. Cancer risk in families with hereditary prostate carcinoma. A possible link between prostate, breast, and gastric carcinoma. Cancer 2000;89:1315-21.
8. Isaacs SD, Kiemeney LALM, Baffoe-Bonnie A, Beaty TH, Walsh PC. Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst 1995;87:991-6.
9. Kiemeney LALM, Witjes JA, Hendrikx AJM, Kil PJM, Vasen HFA. Erfelijk prostaatcarcinoom. Ned Tijdschr Geneeskd 1996;140: 1068-72.
10. Giard RWM, Coebergh JWW, Casparie-van Velsen IJAMG. Sterke stijging van de detectiefrequentie van prostaatkanker in Nederland gedurende de periode 1990-1996. Ned Tijdschr Geneeskd 1998;142: 1958-62.
11. Valeri A, Azzouzi R, Drelon E, Delannoy A, Mangin P, Fournier G, et al. Early-onset hereditary prostate cancer is not associated with specific clinical and biological features. Prostate 2000;45:66-71.
12. Paiss T, Bochum S, Herkommer K, Maier C, Roesch K, Taweemonkonsap T, et al. Hereditary prostate cancer in Germany. Eur Urol 2001;39 Suppl 4:12-8.
13. Ekman P. Genetic and environmental factors in prostate cancer genesis: identifying high-risk cohorts. Eur Urol 1999;35:362-9.
14. Wilson JMG, Jungner G. Principles and practice of screening for disease. Genève: WHO; 1968.
15. Visser O, Horenblas S. Incidentie en behandeling van prostaatcarcinoom in de regio van het Integraal Kankercentrum Amsterdam, 1989-1994. Ned Tijdschr Geneeskd 1996;140:2627-31.
16. Boyle P, Gandini S, Baglietto L, Severi G, Robertson C. Epidemiology of prostate cancer. Eur Urol 2001;39 Suppl 4:2-3.
17. Gezondheidsraad. Commissie WBO. Wet bevolkingsonderzoek: erfelijke prostaatkanker. Publicatienr 2001/01. Den Haag: Gezondheidsraad; 2001.